Lv7
4770 积分 2021-08-07 加入
Dose-reduced (24 Gy) involved-site radiotherapy combined with rituximab in early-stage non-gastric mucosa-associated lymphoid tissue lymphoma: a prospective phase II trial
6小时前
待确认
Allogeneic versus autologous stem cell transplantation for extranodal NK/T-Cell lymphoma: A systematic review and meta-analysis
10天前
已完结
The next 25 years of cancer research: emerging perspectives and priorities
11天前
已完结
Mosunetuzumab With Response-Adapted Polatuzumab Vedotin and Obinutuzumab in Untreated Indolent B-Cell Non-Hodgkin Lymphoma
20天前
已完结
Mosunetuzumab and Polatuzumab Vedotin as First-line Treatment for Large B Cell Lymphoma in Older Unfit or Frail Patients
20天前
已关闭
Mechanisms and interventions in relapsed/refractory extranodal natural killer/T-cell lymphoma
1个月前
已完结
Extranodal natural killer/T-cell lymphoma: An overview on pathology and clinical management
1个月前
已完结
Review on natural killer/T‐cell lymphoma
1个月前
已完结
Integrative Molecular Analysis Reveals Determinants of Clinical Outcomes in TP53 -Mutated Diffuse Large B-Cell Lymphoma
1个月前
已完结
Technical Considerations in the choice and use of ctDNA for Large B-cell lymphoma (LBCL)
1个月前
已关闭
皖公网安备34019202002308
